Assessment of Modifiable Factors for the Association of Marital Status With Cancer-Specific Survival
Zihang Chen(Jinan University), Lin Li(Fujian Medical University), Xiaojing Du(Sun Yat-sen University), Guang‐Li Zhu(Sun Yat-sen University), Guan‐Qun Zhou(Sun Yat-sen University), Ying Sun(Key Laboratory of Guangdong Province), Dan‐Wan Wen(Sun Yat-sen University), Cheng Xu(Sun Yat-sen University), Lei Chen(Zhuzhou Central Hospital), Qing Liu(Central South University), Jun Ma(Shanghai Institute of Technology), Jia‐Wei Lv(Sun Yat-sen University), Yuan-Zhe Zhang(Sun Yat-sen University), Chen‐Fei Wu(Sun Yat-sen University), Kai‐Bin Yang(Sun Yat-sen University Cancer Center)
Cited by 93
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
A Metagenomic Approach to Characterization of the Vaginal Microbiome Signature in Pregnancy
|PLoS ONE|2012|703